nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.176	0.282	CbGbCtD
Rosiglitazone—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0866	0.139	CbGbCtD
Rosiglitazone—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0721	0.116	CbGbCtD
Rosiglitazone—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0632	0.102	CbGbCtD
Rosiglitazone—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0604	0.0971	CbGbCtD
Rosiglitazone—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0577	0.0927	CbGbCtD
Rosiglitazone—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0365	0.0586	CbGbCtD
Rosiglitazone—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0282	0.0454	CbGbCtD
Rosiglitazone—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0259	0.0416	CbGbCtD
Rosiglitazone—ACSL4—Synthesis of very long-chain fatty acyl-CoAs—HSD17B12—peripheral nervous system neoplasm	0.0203	0.251	CbGpPWpGaD
Rosiglitazone—ACSL4—Fatty Acyl-CoA Biosynthesis—HSD17B12—peripheral nervous system neoplasm	0.0168	0.207	CbGpPWpGaD
Rosiglitazone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0159	0.0255	CbGbCtD
Rosiglitazone—ACSL4—Triglyceride Biosynthesis—HSD17B12—peripheral nervous system neoplasm	0.00928	0.114	CbGpPWpGaD
Rosiglitazone—PPARG—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.00562	0.727	CbGdCrCtD
Rosiglitazone—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.00279	0.0343	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00227	0.0279	CbGpPWpGaD
Rosiglitazone—PPARG—Teniposide—Etoposide—peripheral nervous system neoplasm	0.0021	0.272	CbGdCrCtD
Rosiglitazone—SLCO1B1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00192	0.0237	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of retinoblastoma protein—SMARCB1—peripheral nervous system neoplasm	0.00132	0.0163	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.00124	0.0153	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00111	0.0137	CbGpPWpGaD
Rosiglitazone—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00107	0.0132	CbGpPWpGaD
Rosiglitazone—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000904	0.0111	CbGpPWpGaD
Rosiglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000855	0.0105	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000732	0.00901	CbGpPWpGaD
Rosiglitazone—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00064	0.00222	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.000636	0.0022	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000635	0.0022	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Etoposide—peripheral nervous system neoplasm	0.000633	0.00219	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00063	0.00218	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00063	0.00218	CcSEcCtD
Rosiglitazone—Myocardial infarction—Etoposide—peripheral nervous system neoplasm	0.000629	0.00218	CcSEcCtD
Rosiglitazone—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000629	0.00774	CbGpPWpGaD
Rosiglitazone—ALB—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.000624	0.00768	CbGpPWpGaD
Rosiglitazone—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000622	0.00215	CcSEcCtD
Rosiglitazone—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.000621	0.00215	CcSEcCtD
Rosiglitazone—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00062	0.00215	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.000618	0.00214	CcSEcCtD
Rosiglitazone—Fluid retention—Epirubicin—peripheral nervous system neoplasm	0.00061	0.00211	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.000607	0.0021	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000602	0.00208	CcSEcCtD
Rosiglitazone—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000601	0.00208	CcSEcCtD
Rosiglitazone—Back pain—Vincristine—peripheral nervous system neoplasm	0.000599	0.00207	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000597	0.00207	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000597	0.00207	CcSEcCtD
Rosiglitazone—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000596	0.00206	CcSEcCtD
Rosiglitazone—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000596	0.00206	CcSEcCtD
Rosiglitazone—Constipation—Topotecan—peripheral nervous system neoplasm	0.000596	0.00206	CcSEcCtD
Rosiglitazone—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000594	0.00206	CcSEcCtD
Rosiglitazone—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000592	0.00205	CcSEcCtD
Rosiglitazone—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000592	0.00205	CcSEcCtD
Rosiglitazone—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.00059	0.00204	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00059	0.00204	CcSEcCtD
Rosiglitazone—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000589	0.00204	CcSEcCtD
Rosiglitazone—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.000588	0.00203	CcSEcCtD
Rosiglitazone—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.000584	0.00202	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	0.000572	0.00198	CcSEcCtD
Rosiglitazone—Anaemia—Vincristine—peripheral nervous system neoplasm	0.000572	0.00198	CcSEcCtD
Rosiglitazone—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.000568	0.00197	CcSEcCtD
Rosiglitazone—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000565	0.00196	CcSEcCtD
Rosiglitazone—Fluid retention—Doxorubicin—peripheral nervous system neoplasm	0.000565	0.00195	CcSEcCtD
Rosiglitazone—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000562	0.00194	CcSEcCtD
Rosiglitazone—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000555	0.00192	CcSEcCtD
Rosiglitazone—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000554	0.00192	CcSEcCtD
Rosiglitazone—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000554	0.00192	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000554	0.00192	CcSEcCtD
Rosiglitazone—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00055	0.0019	CcSEcCtD
Rosiglitazone—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00055	0.0019	CcSEcCtD
Rosiglitazone—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000547	0.00189	CcSEcCtD
Rosiglitazone—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000547	0.00189	CcSEcCtD
Rosiglitazone—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000547	0.00189	CcSEcCtD
Rosiglitazone—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000545	0.00189	CcSEcCtD
Rosiglitazone—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000542	0.00188	CcSEcCtD
Rosiglitazone—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000538	0.00186	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.000537	0.00186	CcSEcCtD
Rosiglitazone—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000535	0.00185	CcSEcCtD
Rosiglitazone—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000534	0.00185	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.000534	0.00185	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.00053	0.00183	CcSEcCtD
Rosiglitazone—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000527	0.00182	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000524	0.00181	CcSEcCtD
Rosiglitazone—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000524	0.00181	CcSEcCtD
Rosiglitazone—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000521	0.0018	CcSEcCtD
Rosiglitazone—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00052	0.0018	CcSEcCtD
Rosiglitazone—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.000519	0.0018	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000515	0.00178	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.000515	0.00178	CcSEcCtD
Rosiglitazone—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000514	0.00178	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000513	0.00178	CcSEcCtD
Rosiglitazone—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000506	0.00175	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000505	0.00175	CcSEcCtD
Rosiglitazone—Oedema—Vincristine—peripheral nervous system neoplasm	0.000505	0.00175	CcSEcCtD
Rosiglitazone—Infection—Vincristine—peripheral nervous system neoplasm	0.000502	0.00174	CcSEcCtD
Rosiglitazone—Asthenia—Topotecan—peripheral nervous system neoplasm	0.0005	0.00173	CcSEcCtD
Rosiglitazone—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.000497	0.00172	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.000497	0.00172	CcSEcCtD
Rosiglitazone—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000496	0.00172	CcSEcCtD
Rosiglitazone—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000496	0.00172	CcSEcCtD
Rosiglitazone—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000495	0.00171	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000495	0.00171	CcSEcCtD
Rosiglitazone—ACSL4—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000494	0.00609	CbGpPWpGaD
Rosiglitazone—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.00171	CcSEcCtD
Rosiglitazone—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000493	0.00171	CcSEcCtD
Rosiglitazone—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00049	0.0017	CcSEcCtD
Rosiglitazone—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00049	0.0017	CcSEcCtD
Rosiglitazone—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000489	0.00169	CcSEcCtD
Rosiglitazone—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000489	0.00169	CcSEcCtD
Rosiglitazone—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000488	0.00169	CcSEcCtD
Rosiglitazone—Back pain—Etoposide—peripheral nervous system neoplasm	0.000485	0.00168	CcSEcCtD
Rosiglitazone—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000483	0.00167	CcSEcCtD
Rosiglitazone—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.000481	0.00166	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000478	0.00166	CcSEcCtD
Rosiglitazone—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000478	0.00166	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000478	0.00165	CcSEcCtD
Rosiglitazone—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000477	0.00165	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000476	0.00165	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.00165	CcSEcCtD
Rosiglitazone—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000473	0.00164	CcSEcCtD
Rosiglitazone—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000473	0.00164	CcSEcCtD
Rosiglitazone—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000467	0.00162	CcSEcCtD
Rosiglitazone—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000466	0.00161	CcSEcCtD
Rosiglitazone—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000463	0.0016	CcSEcCtD
Rosiglitazone—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000461	0.0016	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00046	0.00159	CcSEcCtD
Rosiglitazone—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.00159	CcSEcCtD
Rosiglitazone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000457	0.00158	CcSEcCtD
Rosiglitazone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000457	0.00158	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000453	0.00157	CcSEcCtD
Rosiglitazone—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000452	0.00156	CcSEcCtD
Rosiglitazone—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000449	0.00155	CcSEcCtD
Rosiglitazone—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000448	0.00155	CcSEcCtD
Rosiglitazone—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000447	0.00155	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000447	0.00155	CcSEcCtD
Rosiglitazone—Infection—Cisplatin—peripheral nervous system neoplasm	0.000444	0.00154	CcSEcCtD
Rosiglitazone—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.00153	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.00153	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.00153	CcSEcCtD
Rosiglitazone—Rash—Topotecan—peripheral nervous system neoplasm	0.00044	0.00152	CcSEcCtD
Rosiglitazone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000439	0.00152	CcSEcCtD
Rosiglitazone—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000438	0.00152	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000437	0.00151	CcSEcCtD
Rosiglitazone—Headache—Topotecan—peripheral nervous system neoplasm	0.000437	0.00151	CcSEcCtD
Rosiglitazone—Rash—Tretinoin—peripheral nervous system neoplasm	0.000436	0.00151	CcSEcCtD
Rosiglitazone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000436	0.00151	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000436	0.00151	CcSEcCtD
Rosiglitazone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000436	0.00151	CcSEcCtD
Rosiglitazone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000436	0.00151	CcSEcCtD
Rosiglitazone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000436	0.00151	CcSEcCtD
Rosiglitazone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000433	0.0015	CcSEcCtD
Rosiglitazone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000433	0.0015	CcSEcCtD
Rosiglitazone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000433	0.0015	CcSEcCtD
Rosiglitazone—Constipation—Vincristine—peripheral nervous system neoplasm	0.000432	0.0015	CcSEcCtD
Rosiglitazone—Rash—Melphalan—peripheral nervous system neoplasm	0.000431	0.00149	CcSEcCtD
Rosiglitazone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00043	0.00149	CcSEcCtD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.000421	0.00519	CbGpPWpGaD
Rosiglitazone—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000417	0.00144	CcSEcCtD
Rosiglitazone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000417	0.00144	CcSEcCtD
Rosiglitazone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000414	0.00143	CcSEcCtD
Rosiglitazone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000411	0.00142	CcSEcCtD
Rosiglitazone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000411	0.00142	CcSEcCtD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000411	0.00506	CbGpPWpGaD
Rosiglitazone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000409	0.00142	CcSEcCtD
Rosiglitazone—PPARG—Regulation of retinoblastoma protein—MET—peripheral nervous system neoplasm	0.000407	0.00502	CbGpPWpGaD
Rosiglitazone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000407	0.00141	CcSEcCtD
Rosiglitazone—Infection—Etoposide—peripheral nervous system neoplasm	0.000407	0.00141	CcSEcCtD
Rosiglitazone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000406	0.0014	CcSEcCtD
Rosiglitazone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000406	0.0014	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000401	0.00139	CcSEcCtD
Rosiglitazone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000387	0.00134	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.00134	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000386	0.00133	CcSEcCtD
Rosiglitazone—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000383	0.00472	CbGpPWpGaD
Rosiglitazone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000376	0.0013	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000375	0.0013	CcSEcCtD
Rosiglitazone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000371	0.00128	CcSEcCtD
Rosiglitazone—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000367	0.00127	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000364	0.00126	CcSEcCtD
Rosiglitazone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000362	0.00125	CcSEcCtD
Rosiglitazone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000359	0.00124	CcSEcCtD
Rosiglitazone—ACSL4—Metabolism—GNS—peripheral nervous system neoplasm	0.000357	0.0044	CbGpPWpGaD
Rosiglitazone—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000357	0.00123	CcSEcCtD
Rosiglitazone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000357	0.00123	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000353	0.00122	CcSEcCtD
Rosiglitazone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000353	0.00122	CcSEcCtD
Rosiglitazone—Constipation—Etoposide—peripheral nervous system neoplasm	0.00035	0.00121	CcSEcCtD
Rosiglitazone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.00035	0.0043	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000349	0.00429	CbGpPWpGaD
Rosiglitazone—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.0012	CcSEcCtD
Rosiglitazone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000347	0.0012	CcSEcCtD
Rosiglitazone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000346	0.0012	CcSEcCtD
Rosiglitazone—ACSL4—Metabolism—NME1—peripheral nervous system neoplasm	0.000343	0.00422	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000341	0.00419	CbGpPWpGaD
Rosiglitazone—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00034	0.00118	CcSEcCtD
Rosiglitazone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.00118	CcSEcCtD
Rosiglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—peripheral nervous system neoplasm	0.000337	0.00416	CbGpPWpGaD
Rosiglitazone—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000337	0.00117	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.00117	CcSEcCtD
Rosiglitazone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000336	0.00116	CcSEcCtD
Rosiglitazone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000334	0.00116	CcSEcCtD
Rosiglitazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000333	0.0041	CbGpPWpGaD
Rosiglitazone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000331	0.00114	CcSEcCtD
Rosiglitazone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00033	0.00114	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.00114	CcSEcCtD
Rosiglitazone—ACSL4—Metabolism—COX2—peripheral nervous system neoplasm	0.00033	0.00406	CbGpPWpGaD
Rosiglitazone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000328	0.00114	CcSEcCtD
Rosiglitazone—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000325	0.00113	CcSEcCtD
Rosiglitazone—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000323	0.00112	CcSEcCtD
Rosiglitazone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000321	0.00111	CcSEcCtD
Rosiglitazone—Rash—Vincristine—peripheral nervous system neoplasm	0.000319	0.0011	CcSEcCtD
Rosiglitazone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000318	0.0011	CcSEcCtD
Rosiglitazone—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000318	0.0011	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000317	0.0011	CcSEcCtD
Rosiglitazone—Headache—Vincristine—peripheral nervous system neoplasm	0.000317	0.0011	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.00109	CcSEcCtD
Rosiglitazone—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.00108	CcSEcCtD
Rosiglitazone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.00108	CcSEcCtD
Rosiglitazone—PPARG—Regulation of retinoblastoma protein—CDKN2A—peripheral nervous system neoplasm	0.000311	0.00383	CbGpPWpGaD
Rosiglitazone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000306	0.00106	CcSEcCtD
Rosiglitazone—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000305	0.00106	CcSEcCtD
Rosiglitazone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000302	0.00104	CcSEcCtD
Rosiglitazone—Nausea—Vincristine—peripheral nervous system neoplasm	0.0003	0.00104	CcSEcCtD
Rosiglitazone—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.0003	0.00104	CcSEcCtD
Rosiglitazone—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.00103	CcSEcCtD
Rosiglitazone—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.00102	CcSEcCtD
Rosiglitazone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000294	0.00102	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.00102	CcSEcCtD
Rosiglitazone—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000292	0.00101	CcSEcCtD
Rosiglitazone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00029	0.001	CcSEcCtD
Rosiglitazone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000285	0.0035	CbGpPWpGaD
Rosiglitazone—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000978	CcSEcCtD
Rosiglitazone—Rash—Cisplatin—peripheral nervous system neoplasm	0.000282	0.000975	CcSEcCtD
Rosiglitazone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000281	0.000974	CcSEcCtD
Rosiglitazone—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000973	CcSEcCtD
Rosiglitazone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00028	0.000969	CcSEcCtD
Rosiglitazone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000966	CcSEcCtD
Rosiglitazone—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.00096	CcSEcCtD
Rosiglitazone—PPARG—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000272	0.00335	CbGpPWpGaD
Rosiglitazone—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000941	CcSEcCtD
Rosiglitazone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000271	0.000937	CcSEcCtD
Rosiglitazone—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000934	CcSEcCtD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000268	0.0033	CbGpPWpGaD
Rosiglitazone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000265	0.000918	CcSEcCtD
Rosiglitazone—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.0009	CcSEcCtD
Rosiglitazone—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000899	CcSEcCtD
Rosiglitazone—Rash—Etoposide—peripheral nervous system neoplasm	0.000258	0.000893	CcSEcCtD
Rosiglitazone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000258	0.000892	CcSEcCtD
Rosiglitazone—Headache—Etoposide—peripheral nervous system neoplasm	0.000256	0.000887	CcSEcCtD
Rosiglitazone—PPARG—Wnt Signaling Pathway Netpath—MYC—peripheral nervous system neoplasm	0.000255	0.00314	CbGpPWpGaD
Rosiglitazone—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000871	CcSEcCtD
Rosiglitazone—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000871	CcSEcCtD
Rosiglitazone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000243	0.000841	CcSEcCtD
Rosiglitazone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000243	0.00084	CcSEcCtD
Rosiglitazone—PPARG—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000242	0.00298	CbGpPWpGaD
Rosiglitazone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000832	CcSEcCtD
Rosiglitazone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000828	CcSEcCtD
Rosiglitazone—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000828	CcSEcCtD
Rosiglitazone—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.000239	0.00294	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000239	0.00294	CbGpPWpGaD
Rosiglitazone—CYP2A6—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000237	0.00291	CbGpPWpGaD
Rosiglitazone—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000806	CcSEcCtD
Rosiglitazone—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000794	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000794	CcSEcCtD
Rosiglitazone—Infection—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000789	CcSEcCtD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.000228	0.00281	CbGpPWpGaD
Rosiglitazone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000779	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000777	CcSEcCtD
Rosiglitazone—PPARG—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000225	0.00276	CbGpPWpGaD
Rosiglitazone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000777	CcSEcCtD
Rosiglitazone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000766	CcSEcCtD
Rosiglitazone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000766	CcSEcCtD
Rosiglitazone—ACSL4—Metabolism—ENO2—peripheral nervous system neoplasm	0.000216	0.00267	CbGpPWpGaD
Rosiglitazone—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000735	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000735	CcSEcCtD
Rosiglitazone—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.00073	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000723	CcSEcCtD
Rosiglitazone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.00072	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000719	CcSEcCtD
Rosiglitazone—CYP2A6—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.0002	0.00246	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.000199	0.00245	CbGpPWpGaD
Rosiglitazone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000685	CcSEcCtD
Rosiglitazone—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000685	CcSEcCtD
Rosiglitazone—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000679	CcSEcCtD
Rosiglitazone—PPARG—Gene Expression—EED—peripheral nervous system neoplasm	0.000195	0.0024	CbGpPWpGaD
Rosiglitazone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000669	CcSEcCtD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.00019	0.00234	CbGpPWpGaD
Rosiglitazone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000634	CcSEcCtD
Rosiglitazone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000633	CcSEcCtD
Rosiglitazone—ACSL4—Metabolism—BCHE—peripheral nervous system neoplasm	0.000183	0.00225	CbGpPWpGaD
Rosiglitazone—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000631	CcSEcCtD
Rosiglitazone—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000628	CcSEcCtD
Rosiglitazone—CYP2A6—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000181	0.00223	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000177	0.00218	CbGpPWpGaD
Rosiglitazone—PPARG—Wnt Signaling Pathway Netpath—AKT1—peripheral nervous system neoplasm	0.000177	0.00218	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000177	0.00218	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000175	0.00215	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—TH—peripheral nervous system neoplasm	0.000172	0.00212	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00017	0.0021	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00017	0.00209	CbGpPWpGaD
Rosiglitazone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000584	CcSEcCtD
Rosiglitazone—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00057	CcSEcCtD
Rosiglitazone—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000562	CcSEcCtD
Rosiglitazone—PTGS1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000157	0.00194	CbGpPWpGaD
Rosiglitazone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000543	CcSEcCtD
Rosiglitazone—PPARG—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000156	0.00192	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000154	0.0019	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000153	0.00189	CbGpPWpGaD
Rosiglitazone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000527	CcSEcCtD
Rosiglitazone—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000525	CcSEcCtD
Rosiglitazone—PPARG—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000152	0.00187	CbGpPWpGaD
Rosiglitazone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00052	CcSEcCtD
Rosiglitazone—CYP2A6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000149	0.00183	CbGpPWpGaD
Rosiglitazone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000503	CcSEcCtD
Rosiglitazone—Rash—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000501	CcSEcCtD
Rosiglitazone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000145	0.0005	CcSEcCtD
Rosiglitazone—Headache—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000497	CcSEcCtD
Rosiglitazone—PPARG—SREBP signalling—AKT1—peripheral nervous system neoplasm	0.000141	0.00174	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—GNAS—peripheral nervous system neoplasm	0.00014	0.00173	CbGpPWpGaD
Rosiglitazone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000486	CcSEcCtD
Rosiglitazone—ACSL4—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000138	0.0017	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000138	0.00169	CbGpPWpGaD
Rosiglitazone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000472	CcSEcCtD
Rosiglitazone—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000463	CcSEcCtD
Rosiglitazone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000463	CcSEcCtD
Rosiglitazone—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.00046	CcSEcCtD
Rosiglitazone—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000436	CcSEcCtD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000126	0.00155	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000125	0.00154	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000119	0.00147	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GNS—peripheral nervous system neoplasm	0.00011	0.00135	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000107	0.00132	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000106	0.00131	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.000106	0.00131	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—NME1—peripheral nervous system neoplasm	0.000105	0.00129	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000102	0.00125	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000101	0.00125	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—COX2—peripheral nervous system neoplasm	0.000101	0.00125	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000101	0.00124	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.0001	0.00124	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	9.93e-05	0.00122	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	9.72e-05	0.0012	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	9.52e-05	0.00117	CbGpPWpGaD
Rosiglitazone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	9.11e-05	0.00112	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.07e-05	0.00112	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	9e-05	0.00111	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	8.86e-05	0.00109	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	8.84e-05	0.00109	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	8.83e-05	0.00109	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	8.64e-05	0.00106	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.34e-05	0.00103	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	8.28e-05	0.00102	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.27e-05	0.00102	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—MET—peripheral nervous system neoplasm	8.14e-05	0.001	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	7.97e-05	0.000981	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	7.8e-05	0.00096	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GNS—peripheral nervous system neoplasm	7.68e-05	0.000946	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—PTPN11—peripheral nervous system neoplasm	7.53e-05	0.000927	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	7.37e-05	0.000907	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GNS—peripheral nervous system neoplasm	7.26e-05	0.000894	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.24e-05	0.000892	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	7.11e-05	0.000875	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	7.11e-05	0.000875	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	7.09e-05	0.000873	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.07e-05	0.00087	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—NME1—peripheral nervous system neoplasm	6.96e-05	0.000858	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	6.96e-05	0.000857	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.86e-05	0.000845	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.82e-05	0.00084	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—COX2—peripheral nervous system neoplasm	6.7e-05	0.000825	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ENO2—peripheral nervous system neoplasm	6.64e-05	0.000818	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.13e-05	0.000754	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—ERBB2—peripheral nervous system neoplasm	5.95e-05	0.000733	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	5.9e-05	0.000726	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.7e-05	0.000702	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.67e-05	0.000698	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.63e-05	0.000694	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—BCHE—peripheral nervous system neoplasm	5.61e-05	0.000691	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.59e-05	0.000688	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	5.47e-05	0.000673	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.36e-05	0.000659	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—TH—peripheral nervous system neoplasm	5.28e-05	0.00065	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	5.23e-05	0.000644	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.14e-05	0.000633	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.09e-05	0.000627	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	4.96e-05	0.000611	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GNS—peripheral nervous system neoplasm	4.93e-05	0.000607	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	4.78e-05	0.000589	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.77e-05	0.000588	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	4.76e-05	0.000586	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NME1—peripheral nervous system neoplasm	4.73e-05	0.000582	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	4.65e-05	0.000573	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.64e-05	0.000572	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	4.58e-05	0.000564	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	4.55e-05	0.000561	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—COX2—peripheral nervous system neoplasm	4.55e-05	0.000561	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—NRAS—peripheral nervous system neoplasm	4.53e-05	0.000557	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	4.48e-05	0.000552	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	4.43e-05	0.000545	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	4.42e-05	0.000544	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	4.4e-05	0.000542	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GNAS—peripheral nervous system neoplasm	4.31e-05	0.000531	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	4.25e-05	0.000523	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ABCB1—peripheral nervous system neoplasm	4.23e-05	0.000521	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.22e-05	0.000519	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	4.16e-05	0.000512	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.14e-05	0.00051	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	4.09e-05	0.000503	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	4.07e-05	0.000502	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.06e-05	0.0005	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	4.04e-05	0.000497	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.97e-05	0.000488	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	3.93e-05	0.000484	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	3.91e-05	0.000481	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	3.87e-05	0.000477	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—AKT1—peripheral nervous system neoplasm	3.79e-05	0.000467	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	3.76e-05	0.000463	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.75e-05	0.000462	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	3.73e-05	0.000459	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	3.72e-05	0.000458	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	3.7e-05	0.000455	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.55e-05	0.000437	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	3.5e-05	0.00043	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	3.45e-05	0.000425	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	3.39e-05	0.000418	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.33e-05	0.00041	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	3.32e-05	0.000409	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—HRAS—peripheral nervous system neoplasm	3.31e-05	0.000408	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	3.31e-05	0.000407	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	3.18e-05	0.000392	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	3.02e-05	0.000372	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	3.01e-05	0.00037	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	2.99e-05	0.000368	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.96e-05	0.000365	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.92e-05	0.00036	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	2.85e-05	0.000351	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.8e-05	0.000345	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	2.68e-05	0.00033	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	2.54e-05	0.000313	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	2.53e-05	0.000311	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.5e-05	0.000308	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	2.47e-05	0.000304	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	2.45e-05	0.000301	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.42e-05	0.000298	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.41e-05	0.000297	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	2.39e-05	0.000294	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TH—peripheral nervous system neoplasm	2.37e-05	0.000292	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	2.27e-05	0.000279	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.16e-05	0.000266	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MYC—peripheral nervous system neoplasm	2.16e-05	0.000266	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	2.13e-05	0.000262	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.09e-05	0.000257	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	2.09e-05	0.000257	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	2.07e-05	0.000255	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	2e-05	0.000246	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.99e-05	0.000245	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.97e-05	0.000243	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.96e-05	0.000241	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	1.95e-05	0.00024	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	1.94e-05	0.000239	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	1.94e-05	0.000239	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	1.91e-05	0.000236	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	1.9e-05	0.000234	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.77e-05	0.000218	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	1.74e-05	0.000214	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	1.71e-05	0.00021	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.69e-05	0.000208	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.66e-05	0.000205	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.6e-05	0.000197	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	1.59e-05	0.000195	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.57e-05	0.000193	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.56e-05	0.000192	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	1.53e-05	0.000188	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—peripheral nervous system neoplasm	1.5e-05	0.000184	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	1.46e-05	0.00018	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.36e-05	0.000167	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.33e-05	0.000164	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	1.29e-05	0.000159	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—peripheral nervous system neoplasm	1.16e-05	0.000143	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	9.16e-06	0.000113	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	8.15e-06	0.0001	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	7.7e-06	9.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	5.26e-06	6.48e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	5.23e-06	6.44e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	4.7e-06	5.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	4.32e-06	5.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	4.28e-06	5.27e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.66e-06	4.51e-05	CbGpPWpGaD
